lifileucel
iovance biotherapeutics
['advance', 'c,144,i', 'ln-144', 'lifileucel', 'c,144,01']
lifileucel (ln-144), an investigational autologous til therapy, showed encouraging efficacy and a manageable safety profile in patients with heavily pretreated advanced melanoma in the phase 2 c-144-01 (nct02360579) clinical trial. #sitc22 #sitc2022 